Hinokitiol as a Potential GPX4 Allosteric Modulator to Prevent Ferroptosis-mediated Neurodegeneration in Parkinson's Disease.

Mohan D, Soujanya C, Venkatesan R, Chakkittukandiyil A, Kandy AT, Kothandan R, Balasubramanian S, Selvaraj D

Open source

DOI
10.1007/s11064-026-04894-5
Published
2026 Sep 17
Container
Neurochemical research
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11064-026-04894-5,
  title = {Hinokitiol as a Potential GPX4 Allosteric Modulator to Prevent Ferroptosis-mediated Neurodegeneration in Parkinson's Disease.},
  author = {Mohan D and Soujanya C and Venkatesan R and Chakkittukandiyil A and Kandy AT and Kothandan R and Balasubramanian S and Selvaraj D},
  year = {2026},
  journal = {Neurochemical research},
  doi = {10.1007/s11064-026-04894-5},
  url = {https://doi.org/10.1007/s11064-026-04894-5}
}

RIS

TY  - JOUR
TI  - Hinokitiol as a Potential GPX4 Allosteric Modulator to Prevent Ferroptosis-mediated Neurodegeneration in Parkinson's Disease.
AU  - Mohan D
AU  - Soujanya C
AU  - Venkatesan R
AU  - Chakkittukandiyil A
AU  - Kandy AT
AU  - Kothandan R
AU  - Balasubramanian S
AU  - Selvaraj D
PY  - 2026
JO  - Neurochemical research
DO  - 10.1007/s11064-026-04894-5
UR  - https://doi.org/10.1007/s11064-026-04894-5
ER  - 

APA

D, M., C, S., R, V., A, C., AT, K., R, K., S, B., & D, S. (2026). Hinokitiol as a Potential GPX4 Allosteric Modulator to Prevent Ferroptosis-mediated Neurodegeneration in Parkinson's Disease.. Neurochemical research. https://doi.org/10.1007/s11064-026-04894-5

Source records